EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trends in Clostridioides difficile Diagnostic Testing Methods in U.S. Acute-Care Hospitals

Sai Pranathi Bingi, Stephanie Stroever, Monika Pogorzelska-Maziarz

Antimicrobial Stewardship & Healthcare Epidemiology · 2026-08 · 6 (S1) · s11-s11

DOI: 10.1017/ash.2026.10442 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Stewardship & Healthcare Epidemiology, online erschienen am 23.06.2026. Verfasst von Sai Pranathi Bingi und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clostridioides difficile infection (CDI) remains a leading healthcare-associated infection (HAI) in the United States. To prevent outbreaks and transmission within healthcare facilities, providers must quickly recognize signs of CDI, correctly diagnose it, and implement measures to contain it. Nucleic acid amplification tests (NAATs) are highly sensitive but may over diagnose CDI, while toxin enzyme immunoassays (EIAs) risk false negatives. Two-step diagnostic algorithms have been recommended to improve diagnostic accuracy; however, national trends in their adoption have not been well described.

Method

We conducted a secondary analysis of data from the Preventing Infections Through Appropriate Staffing (PITAS) study, which includes annual National Healthcare Safety Network (NHSN) hospital survey data from 347 U.S. acute-care hospitals from 2011-2024. Hospitals reported CDI testing methods annually, which were categorized as one-step, two-step, or other algorithms. Temporal trends in two-step testing adoption were assessed using mixed-effects linear regression with hospital as a random effect and adjustment for bed size and academic affiliation. Stratified analyses were performed by hospital size and academic status.

Result

A total of 347 acute care hospitals contributed data from 2011-2024. In 2012, the predominant testing method was NAAT alone, which was utilized by 58% of hospitals while only 6.25% of hospitals utilized two-step methodologies. In 2017, the year of publication of the updated Infectious Disease Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) Clinical Practice Guidelines, 28.75% of hospitals used two-step methods. By 2024, 66.18% of surveyed hospitals utilized two-step methodologies for CDI. Academic hospitals consistently demonstrated higher adoption rates than non-academic hospitals (11.11% vs 2.92% in 2012 and 67.35% vs 59.18% in 2024). Hospitals with 501-1000 beds had significantly higher odds of adopting two-step testing compared with the smallest hospitals.

Conclusion

Use of two-step CDI testing methods increased substantially in U.S. acute-care hospitals from 2011- 2024, particularly following the 2017 IDSA and SHEA guideline update. As hospitals increasingly adopt two-step testing, policymakers and healthcare epidemiologists should consider how testing methods influence reported infection rates.

Zitieren

APA

Bingi, S. P., Stroever, S., & Pogorzelska-Maziarz, M. (2026). Trends in Clostridioides difficile Diagnostic Testing Methods in U.S. Acute-Care Hospitals. Antimicrobial Stewardship & Healthcare Epidemiology, 6(S1), s11-s11. https://doi.org/10.1017/ash.2026.10442

Vancouver

Bingi SP, Stroever S, Pogorzelska-Maziarz M. Trends in Clostridioides difficile Diagnostic Testing Methods in U.S. Acute-Care Hospitals. Antimicrobial Stewardship & Healthcare Epidemiology. 2026;6(S1):s11-s11. doi:10.1017/ash.2026.10442

BibTeX
@article{Bingi2026,
  author = {Bingi, Sai Pranathi and Stroever, Stephanie and Pogorzelska-Maziarz, Monika},
  title = {Trends in Clostridioides difficile Diagnostic Testing Methods in U.S. Acute-Care Hospitals},
  journal = {Antimicrobial Stewardship & Healthcare Epidemiology},
  year = {2026},
  volume = {6},
  number = {S1},
  pages = {s11--s11},
  doi = {10.1017/ash.2026.10442}
}
Kostenlos starten →